New Delhi, August 23
Recoveries among Covid-19 patients in the country surged to 22,80,566 on Sunday, pushing India's recovery rate to nearly 75 per cent, while the case fatality rate reduced to 1.86 per cent — one of the lowest globally, the Union Health Ministry said.
Health Minister Harsh Vardhan tweeted, "If all goes well, India should have a Covid vaccine by year-end."
The government is banking on three vaccine candidates under human trials in India. While Bharat Biotech and ICMR vaccine Covaxin and Zydus Cadila's candidate have completed phase 1 human trials and begun phase 2, Oxford University and Serum Institute's Covishield is at a more advanced stage.
Serum Institute today said, at present, the government had granted them permission to only manufacture the vaccine and stockpile it for future use. "Covishield will be commercialised once the trials are proven successful and all requisite regulatory approvals are in place," it said. — TNS

from The Tribune https://ift.tt/32i8F7g
No comments:
Post a Comment